These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 568029)
1. Androgen-estrogen production rates in postmenopausal women with breast cancer. Kirschner MA; Cohen FB; Ryan C Cancer Res; 1978 Nov; 38(11 Pt 2):4029-35. PubMed ID: 568029 [No Abstract] [Full Text] [Related]
2. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642 [TBL] [Abstract][Full Text] [Related]
3. Increases in serum estrogen levels during major illness are caused by increased peripheral aromatization. Spratt DI; Morton JR; Kramer RS; Mayo SW; Longcope C; Vary CP Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E631-8. PubMed ID: 16670151 [TBL] [Abstract][Full Text] [Related]
4. Relationship between urine and plasma estrogen ratios. Longcope C; Pratt JH Cancer Res; 1978 Nov; 38(11 Pt 2):4025-8. PubMed ID: 698950 [TBL] [Abstract][Full Text] [Related]
5. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones. Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882 [TBL] [Abstract][Full Text] [Related]
6. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1). Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513 [TBL] [Abstract][Full Text] [Related]
7. Plasma levels of estrone, estrone sulfate, and estradiol and the percentage of unbound estradiol in postmenopausal women with and without breast disease. Reed MJ; Cheng RW; Noel CT; Dudley HA; James VH Cancer Res; 1983 Aug; 43(8):3940-3. PubMed ID: 6683128 [TBL] [Abstract][Full Text] [Related]
8. Changes in reproductive hormones and sex hormone-binding globulin in a group of postmenopausal women measured over 10 years. Jiroutek MR; Chen MH; Johnston CC; Longcope C Menopause; 1998; 5(2):90-4. PubMed ID: 9689202 [TBL] [Abstract][Full Text] [Related]
10. Sex hormones in postmenopausal women with primary biliary cirrhosis. Becker U; Almdal T; Christensen E; Gluud C; Farholt S; Bennett P; Svenstrup B; Hardt F Hepatology; 1991 May; 13(5):865-9. PubMed ID: 1827631 [TBL] [Abstract][Full Text] [Related]
11. Androgen and SHBG serum concentrations in late post-menopause women. Skałba P; Wójtowicz M; Sikora J Med Sci Monit; 2003 Mar; 9(3):CR152-6. PubMed ID: 12640346 [TBL] [Abstract][Full Text] [Related]
12. Profound suppression of plasma estrogens by megestrol acetate in postmenopausal breast cancer patients. Lundgren S; Helle SI; Lonning PE Clin Cancer Res; 1996 Sep; 2(9):1515-21. PubMed ID: 9816328 [TBL] [Abstract][Full Text] [Related]
13. Lack of diurnal variation in plasma levels of androstenedione, testosterone, estrone and estradiol in postmenopausal women. Lønning PE; Dowsett M; Jacobs S; Schem B; Hardy J; Powles TJ J Steroid Biochem; 1989; 34(1-6):551-3. PubMed ID: 2626050 [TBL] [Abstract][Full Text] [Related]
14. [Hormones and breast cancer. Current views]. Molinatti GM; Limone P Minerva Med; 1982 Apr; 73(17):1047-53. PubMed ID: 6281687 [No Abstract] [Full Text] [Related]
15. Endocrine status in stage II vs. advanced premenopausal and postmenopausal breast cancer patients. Bhatavdekar JM; Patel DD; Shah NG; Giri DD; Vora HH; Karelia NH; Trivedi SN; Ghosh N; Suthar TP Neoplasma; 1992; 39(1):39-42. PubMed ID: 1388248 [TBL] [Abstract][Full Text] [Related]
16. [The estrogen-androgen profile is unchanged in men with cholelithiasis]. Cohen G; Davion T; Capron D; Arlot S; Degrelle H; Wright F; Capron JP Gastroenterol Clin Biol; 1992; 16(4):299-301. PubMed ID: 1397846 [TBL] [Abstract][Full Text] [Related]
17. Serum steroid hormone levels, sex hormone-binding globulin, and body mass index in the etiology of postmenopausal breast cancer. Lipworth L; Adami HO; Trichopoulos D; Carlström K; Mantzoros C Epidemiology; 1996 Jan; 7(1):96-100. PubMed ID: 8664410 [TBL] [Abstract][Full Text] [Related]
18. Dose-related endocrine effects and pharmacokinetics of oral and intramuscular 4-hydroxyandrostenedione in postmenopausal breast cancer patients. Dowsett M; Cunningham DC; Stein RC; Evans S; Dehennin L; Hedley A; Coombes RC Cancer Res; 1989 Mar; 49(5):1306-12. PubMed ID: 2917360 [TBL] [Abstract][Full Text] [Related]
19. Serum concentrations of estrone, androstenedione, testosterone and sex-hormone-binding globulin in postmenopausal women with breast cancer and in age-matched controls. Adami HO; Johansson ED; Vegelius J; Victor A Ups J Med Sci; 1979; 84(3):259-74. PubMed ID: 575585 [TBL] [Abstract][Full Text] [Related]
20. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]